|
|
|
Meet The CALTCM Board of Directors:
Karl Steinberg, MD, CMD
CALTCM BOD, Secretary, & Co-Chair PPSC
Dr. Karl Steinberg is an experienced clinician with over 20 years in practice in San Diego County. He is a
geriatrician and board-certified family physician with a subspecialty certification in hospice and palliative
medicine. He serves as chief medical officer for Shea Family Health, an El Cajon-based nursing home
and post-acute care chain, medical director of two other skilled nursing facilities, Kindred Village Square
and Life Care Center of Vista, and medical director of Hospice by the Sea in Solana Beach. Dr. Steinberg
has been a nursing home medical director and hospice medical director since 1995 and is probably best
known for taking his dogs on rounds with him almost every day. He is the editor-in-chief of Caring for the
Ages, and on AMDA's BOD and vice chair of their Public Policy Committee, and chair-elect of the Coalition
for Compassionate Care of CA. Dr. Steinberg was also CALTCM President from 2007-2009.
|
|
Read more...
|
|
|
2015 Call for Nominations |
2015 CALTCM Leadership Award
The CALTCM Leadership Award recognizes individuals who have demonstrated exceptional leadership and made outstanding contributions in the areas of education, practice, administration or policy in long term care. This leadership is characterized by results of increased visibility of critical issues, creation of solutions to significant problems, and positive impacts on the overall quality of care in long term care.
|
|
Read more...
|
ASK CALTCM
Are you ever frustrated when a question comes up in your day to day routine in long term care? It may be a regulatory question, a clinical one, or simply a practical management issue. The Wave is bravely offering the expertise of our editorial staff, and if we don't know the answer we may have contacts that do. Simply send a question our way and give us a chance to be helpful. The odds are great that if you find the question a challenge so do many of our other readers. Just submit your question or problem to [email protected]. |
|
by Flora Y. Bessey, PharmD, CGP
This past month you have heard the awesome accomplishment the ice bucket challenge has generated for ALS donations and overall awareness. Along the same lines, I challenge you all to learn the IDT process at your facility surrounding antipsychotic medication use.
The CDPH All Facilities Letter which came out earlier this month is very specific about the expectations from facilities for resident with antipsychotics. (Read Dr. Tim Gieseke’s article Added Incentive to Reduce Inappropriate Antipsychotic Use.)
|
|
Read more...
|
|
Hydrocodone Products Move to Schedule II Controlled Substances October 6, 2014 |
|
by Janice Hoffman, PharmD, CGP, FASCP
As most of you have heard, Hydrocodone containing combination products are moving to Schedule II controlled substance status on October 6th, 2014 whether as health professional we agree or not. Pharmacologically, Hydrocodone is metabolized to hydromorphone, a schedule II opioid, and also have similar mechanisms of action to other schedule II opioids including oxycodone, morphine, and fentanyl, suggesting that abuse potential would be comparable. 2
|
|
Read more...
|
|
|
|
|
<< first < Prev 41 42 43 44 45 46 47 48 49 50 Next > last >>
|
|
Page 50 of 78 |
